Lif broadly supportive of report on Danish healthcare

12 August 2024

The Danish Pharmaceutical Industry Association, Lif, has submitted its consultation response to the Health Structure Commission's report, which was published in June.

Lif is broadly complimentary of the report in its response, and shares the government and the Health Structure Commission's analysis that the current system does not match the health service's present needs and especially the challenges of the coming years.  

Ida Sofie Jensen, chief executive of the group, said: “It is important to have a strong public healthcare system, where there is easy and quick access as well as time and resources for the individual patient. A healthcare service with high quality, regardless of whether the patient fails something "ordinary" or something that requires specialized efforts, and regardless of where in the country the patient lives.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical